How to reduce the risk of primary engraftment failure after haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia?

How to reduce the risk of primary engraftment failure after haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia?

Background. Haploidentical hematopoietic stem cell transplantation (haplo‑HSCT) represents an important alternative for patients with acute myeloid leukemia (AML) who lack an HLA‑matched donor. However, the high incidence of primary graft failure remains a significant challenge. Optimizing transplan...

Full description

Saved in:
Bibliographic Details
Main Authors: D. K. Zhogolev, S. N. Bondarenko, A. G. Smirnova, Yu. Yu. Vlasova, D. A. Chernyshova, I. S. Moiseev, A. D. Kulagin
Format: Article
Language:Russian
Published: ABV-press 2025-03-01
Series:Онкогематология
Subjects:
haploidentical hematopoietic stem cell transplantation
acute myeloid leukemia
engraftment
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/1010
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items